Nifedipine | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Nifedipine
USP

munit-sa-m-2025-04-14

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Nifedipine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 38 USDMF, 11 CEP/COS, 7 JDMF, 6 EU WC, 5 KDMF, 18 NDC API, 19 Listed Suppliers, $ API Reference Price

69 API Suppliers
38 USDMF
11 CEP/COS
7 JDMF
6 EU WC
5 KDMF
18 NDC API
19 Listed Suppliers
$ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

276 FDF Dossiers, 75 FDA Orange Book, 100 Europe, 18 Canada, 4 Australia, 32 South Africa, 47 Listed Dossiers

276 FDF Dossiers
75 FDA Orange Book
100 Europe
18 Canada
4 Australia
32 South Africa
47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 90MG, TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 10MG
CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 30MG
TABLET, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE;ORAL - 90MG
TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 7 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 14 DKSH, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 1 Clariant, 12 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 8 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 24 Roquette, 10 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 40 Controlled & Modified Release, 29 Thickeners and Stabilizers, 24 Solubilizers, 23 Film Formers & Plasticizers, 23 Granulation, 23 Direct Compression, 21 Topical, 20 Parenteral, 20 Taste Masking, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 10 Disintegrants & Superdisintegrants, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 8 Rheology Modifiers, 7 Emulsifying Agents, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

77 Fillers, Diluents & Binders
63 Coating Systems & Additives
40 Controlled & Modified Release
29 Thickeners and Stabilizers
24 Solubilizers
23 Film Formers & Plasticizers
23 Granulation
23 Direct Compression
21 Topical
20 Parenteral
20 Taste Masking
16 Lubricants & Glidants
14 Co-Processed Excipients
10 Disintegrants & Superdisintegrants
9 Empty Capsules
8 Chewable & Orodispersible Aids
8 Rheology Modifiers
7 Emulsifying Agents
6 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

19 News #PharmaBuzz

19 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 106 Regulatory FDF Prices, 10 Annual Reports

2 US Medicaid Prescriptions
106 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

20 APIs, 17 FDF Dossiers

20 APIs
17 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 15 Others

3 EDQM
3 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 81 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11463508

02 11463600

03 11463701

filter Description Reset all filters

3 All

01 1Nifedipine (125 mg)

02 1Nifedipine Nitrophenylpyridine Analog (25 mg)

03 1Nifedipine Nitrosophenylpyridine Analog (25 mg) (Dimethyl 4-(2-nitrosophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)

filter CAS Number Reset all filters

3 All

01 121829-25-4

02 2N/A

Product Main Page

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Nifedipine Nitrosophenylpyridine Analog (25 m...

CAS Number : N/A

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1463701

Current Lot : R02230

Previous Lot : K1F147 (31-DEC-2016)

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Nifedipine Nitrophenylpyridine Analog (25 mg)

CAS Number : N/A

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1463600

Current Lot : R052Y0

Previous Lot : R021S0 (31-DEC-2017)

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Nifedipine (125 mg)

CAS Number : 21829-25-4

Quantity Per Vial :

Price ($) : 185

Catalog Number : 1463508

Current Lot : R051Q0

Previous Lot : L0J059 (31-DEC-2017)

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!